| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colonoscopy | 7 | 2019 | 518 | 1.100 |
Why?
|
| Adenoma | 6 | 2017 | 716 | 1.000 |
Why?
|
| Colitis | 6 | 2019 | 340 | 0.560 |
Why?
|
| Endoscopic Mucosal Resection | 1 | 2016 | 94 | 0.500 |
Why?
|
| Colonic Polyps | 2 | 2016 | 209 | 0.470 |
Why?
|
| Leukocytes | 1 | 2014 | 422 | 0.420 |
Why?
|
| Colonic Neoplasms | 18 | 2016 | 1390 | 0.410 |
Why?
|
| Genetic Markers | 1 | 2014 | 974 | 0.400 |
Why?
|
| Telomere | 1 | 2014 | 505 | 0.390 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2011 | 334 | 0.330 |
Why?
|
| DNA Copy Number Variations | 1 | 2014 | 1516 | 0.300 |
Why?
|
| Intestinal Neoplasms | 2 | 2006 | 189 | 0.300 |
Why?
|
| Colorectal Neoplasms | 3 | 2019 | 3578 | 0.290 |
Why?
|
| Bile Duct Neoplasms | 1 | 2011 | 493 | 0.270 |
Why?
|
| Cholangiocarcinoma | 1 | 2011 | 493 | 0.270 |
Why?
|
| Stomach Neoplasms | 7 | 2014 | 2278 | 0.240 |
Why?
|
| Intestine, Small | 2 | 2006 | 499 | 0.230 |
Why?
|
| SOX9 Transcription Factor | 2 | 2014 | 170 | 0.220 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2014 | 4549 | 0.210 |
Why?
|
| Adenocarcinoma | 6 | 2017 | 7789 | 0.200 |
Why?
|
| Rectal Neoplasms | 15 | 1987 | 1202 | 0.200 |
Why?
|
| Endoscopy, Digestive System | 2 | 2019 | 202 | 0.190 |
Why?
|
| Gastrointestinal Hemorrhage | 4 | 2018 | 340 | 0.180 |
Why?
|
| Colon | 5 | 2018 | 670 | 0.170 |
Why?
|
| Self Expandable Metallic Stents | 1 | 2019 | 12 | 0.170 |
Why?
|
| Antineoplastic Agents, Immunological | 2 | 2019 | 1249 | 0.170 |
Why?
|
| Zenker Diverticulum | 1 | 2019 | 10 | 0.170 |
Why?
|
| Middle Aged | 41 | 2019 | 86204 | 0.170 |
Why?
|
| Neoplasms | 10 | 2019 | 15193 | 0.170 |
Why?
|
| Transforming Growth Factor beta | 2 | 2016 | 1130 | 0.170 |
Why?
|
| Aged | 32 | 2019 | 70117 | 0.170 |
Why?
|
| Diarrhea | 4 | 2018 | 686 | 0.160 |
Why?
|
| Proto-Oncogenes | 1 | 2018 | 202 | 0.160 |
Why?
|
| Digestive System Neoplasms | 1 | 2018 | 82 | 0.160 |
Why?
|
| Colectomy | 2 | 2019 | 288 | 0.160 |
Why?
|
| Antibodies, Monoclonal | 3 | 2018 | 4367 | 0.160 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2018 | 149 | 0.150 |
Why?
|
| Male | 45 | 2019 | 123000 | 0.150 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2019 | 278 | 0.150 |
Why?
|
| Ipilimumab | 2 | 2018 | 710 | 0.150 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2016 | 32 | 0.150 |
Why?
|
| Fanconi Anemia Complementation Group D2 Protein | 1 | 2016 | 41 | 0.150 |
Why?
|
| Occult Blood | 4 | 1985 | 64 | 0.150 |
Why?
|
| Intestinal Obstruction | 2 | 2019 | 202 | 0.140 |
Why?
|
| Thrombocytopenia | 7 | 2018 | 846 | 0.140 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2018 | 270 | 0.140 |
Why?
|
| Real-Time Polymerase Chain Reaction | 3 | 2016 | 1217 | 0.140 |
Why?
|
| Pregnancy, Animal | 1 | 2016 | 92 | 0.140 |
Why?
|
| Esophageal Neoplasms | 4 | 2014 | 3168 | 0.140 |
Why?
|
| Nutrition Assessment | 1 | 2017 | 169 | 0.140 |
Why?
|
| Neutropenia | 5 | 2018 | 968 | 0.140 |
Why?
|
| Proton Pump Inhibitors | 1 | 2019 | 249 | 0.140 |
Why?
|
| Nucleoproteins | 1 | 2016 | 37 | 0.140 |
Why?
|
| Spectrin | 1 | 2016 | 85 | 0.140 |
Why?
|
| Neoplastic Stem Cells | 2 | 2014 | 1443 | 0.140 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2016 | 222 | 0.130 |
Why?
|
| Female | 42 | 2019 | 141928 | 0.130 |
Why?
|
| Humans | 66 | 2019 | 261506 | 0.130 |
Why?
|
| Clostridium Infections | 1 | 2019 | 252 | 0.130 |
Why?
|
| Bevacizumab | 1 | 2019 | 938 | 0.130 |
Why?
|
| Texas | 6 | 2019 | 6311 | 0.130 |
Why?
|
| Phosphoinositide Phospholipase C | 1 | 2014 | 13 | 0.130 |
Why?
|
| Malnutrition | 1 | 2017 | 218 | 0.120 |
Why?
|
| Immunologic Factors | 1 | 2018 | 649 | 0.120 |
Why?
|
| Natural Language Processing | 1 | 2015 | 119 | 0.120 |
Why?
|
| Mucin-1 | 1 | 2014 | 127 | 0.120 |
Why?
|
| Psychophysiologic Disorders | 1 | 1994 | 29 | 0.120 |
Why?
|
| Fluorouracil | 6 | 2014 | 1944 | 0.120 |
Why?
|
| Genomic Instability | 1 | 2016 | 519 | 0.120 |
Why?
|
| GPI-Linked Proteins | 1 | 2014 | 223 | 0.120 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2016 | 287 | 0.110 |
Why?
|
| Documentation | 1 | 2015 | 207 | 0.110 |
Why?
|
| Postoperative Complications | 4 | 2019 | 5542 | 0.110 |
Why?
|
| Immunoenzyme Techniques | 2 | 2016 | 1165 | 0.110 |
Why?
|
| Retrospective Studies | 10 | 2019 | 37905 | 0.110 |
Why?
|
| Patient Safety | 1 | 2018 | 649 | 0.110 |
Why?
|
| Mood Disorders | 1 | 1994 | 163 | 0.110 |
Why?
|
| DNA, Mitochondrial | 1 | 2014 | 311 | 0.110 |
Why?
|
| Lymphangioma, Cystic | 1 | 2012 | 20 | 0.110 |
Why?
|
| Smad3 Protein | 1 | 2013 | 129 | 0.110 |
Why?
|
| Mutation | 3 | 2017 | 15179 | 0.110 |
Why?
|
| Gastrointestinal Diseases | 5 | 1994 | 589 | 0.100 |
Why?
|
| Adult | 29 | 2019 | 77950 | 0.100 |
Why?
|
| Receptor, Notch1 | 1 | 2013 | 218 | 0.100 |
Why?
|
| Quality Indicators, Health Care | 1 | 2015 | 348 | 0.100 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2014 | 413 | 0.100 |
Why?
|
| Endoscopes, Gastrointestinal | 1 | 1990 | 13 | 0.100 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2018 | 1823 | 0.090 |
Why?
|
| Precancerous Conditions | 1 | 2017 | 1058 | 0.090 |
Why?
|
| Incidence | 3 | 2011 | 5673 | 0.090 |
Why?
|
| Metformin | 1 | 2014 | 378 | 0.090 |
Why?
|
| Microfilament Proteins | 1 | 2013 | 487 | 0.090 |
Why?
|
| Pancreatic Neoplasms | 4 | 2018 | 5061 | 0.090 |
Why?
|
| Neoplasm, Residual | 1 | 2016 | 1656 | 0.090 |
Why?
|
| Subtraction Technique | 1 | 2010 | 141 | 0.090 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2018 | 907 | 0.090 |
Why?
|
| Sex Distribution | 1 | 2011 | 495 | 0.090 |
Why?
|
| Fluoroscopy | 1 | 1990 | 232 | 0.090 |
Why?
|
| Age Distribution | 1 | 2011 | 698 | 0.090 |
Why?
|
| Odds Ratio | 1 | 2014 | 2316 | 0.080 |
Why?
|
| Intestinal Diseases | 1 | 2010 | 121 | 0.080 |
Why?
|
| Early Detection of Cancer | 2 | 2015 | 1258 | 0.080 |
Why?
|
| Case-Control Studies | 2 | 2019 | 6100 | 0.080 |
Why?
|
| Antineoplastic Agents | 11 | 2019 | 14289 | 0.080 |
Why?
|
| Video Recording | 1 | 1990 | 267 | 0.080 |
Why?
|
| Phosphoproteins | 1 | 2014 | 1152 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 3 | 2019 | 2992 | 0.080 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 1 | 2013 | 425 | 0.080 |
Why?
|
| Survival Rate | 4 | 2019 | 12221 | 0.080 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 2330 | 0.080 |
Why?
|
| Bacterial Infections | 1 | 2012 | 479 | 0.080 |
Why?
|
| Biopsy | 3 | 2012 | 3443 | 0.080 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 1439 | 0.080 |
Why?
|
| Antigens, Neoplasm | 1 | 2014 | 1506 | 0.080 |
Why?
|
| Age Factors | 5 | 2018 | 5377 | 0.080 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2018 | 1724 | 0.080 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 1546 | 0.070 |
Why?
|
| Logistic Models | 1 | 2014 | 3441 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 1 | 2014 | 1491 | 0.070 |
Why?
|
| Nitrosourea Compounds | 2 | 1983 | 12 | 0.070 |
Why?
|
| Carrier Proteins | 1 | 2013 | 2022 | 0.060 |
Why?
|
| Prognosis | 7 | 2019 | 21713 | 0.060 |
Why?
|
| Colonic Diseases | 1 | 1985 | 71 | 0.060 |
Why?
|
| Blotting, Western | 3 | 2016 | 3536 | 0.060 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2010 | 1226 | 0.060 |
Why?
|
| Hepatectomy | 1 | 2011 | 1011 | 0.060 |
Why?
|
| Semustine | 2 | 1982 | 2 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2018 | 8873 | 0.060 |
Why?
|
| Time Factors | 5 | 2019 | 12926 | 0.060 |
Why?
|
| Gastrointestinal Agents | 1 | 2004 | 108 | 0.060 |
Why?
|
| Psoriasis | 1 | 2004 | 126 | 0.060 |
Why?
|
| Analysis of Variance | 2 | 2018 | 2307 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2019 | 7551 | 0.060 |
Why?
|
| Immunoprecipitation | 2 | 2016 | 591 | 0.060 |
Why?
|
| Transcription Factors | 2 | 2014 | 5270 | 0.060 |
Why?
|
| Hepatitis | 1 | 1983 | 93 | 0.060 |
Why?
|
| Mitomycins | 3 | 1982 | 48 | 0.050 |
Why?
|
| Phenotype | 1 | 2014 | 6295 | 0.050 |
Why?
|
| Signal Transduction | 3 | 2016 | 11965 | 0.050 |
Why?
|
| Neoplasm Proteins | 1 | 2014 | 3230 | 0.050 |
Why?
|
| Endosonography | 2 | 2019 | 536 | 0.050 |
Why?
|
| Comorbidity | 2 | 2019 | 2352 | 0.050 |
Why?
|
| Mice, Nude | 3 | 2014 | 4307 | 0.050 |
Why?
|
| Intestinal Mucosa | 3 | 2018 | 1081 | 0.050 |
Why?
|
| Heterografts | 2 | 2014 | 733 | 0.050 |
Why?
|
| Vinblastine | 1 | 1982 | 453 | 0.050 |
Why?
|
| Positron-Emission Tomography | 1 | 2010 | 2173 | 0.050 |
Why?
|
| United States | 2 | 2018 | 15433 | 0.050 |
Why?
|
| Drug Evaluation | 11 | 1986 | 425 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2014 | 5539 | 0.050 |
Why?
|
| Peritoneovenous Shunt | 1 | 1980 | 6 | 0.050 |
Why?
|
| Nephritis | 1 | 1980 | 36 | 0.050 |
Why?
|
| Anemia, Hemolytic | 1 | 1980 | 53 | 0.050 |
Why?
|
| Guaiac | 2 | 1976 | 6 | 0.050 |
Why?
|
| Mycoses | 1 | 1983 | 386 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 29902 | 0.040 |
Why?
|
| Ascites | 1 | 1980 | 198 | 0.040 |
Why?
|
| Colostomy | 1 | 2019 | 70 | 0.040 |
Why?
|
| Radiography | 4 | 2012 | 1904 | 0.040 |
Why?
|
| Transfection | 2 | 2014 | 2944 | 0.040 |
Why?
|
| Leukemia, Myeloid | 1 | 1983 | 941 | 0.040 |
Why?
|
| Registries | 1 | 2006 | 2170 | 0.040 |
Why?
|
| Diagnosis, Differential | 5 | 2019 | 4744 | 0.040 |
Why?
|
| Pregnancy Complications | 1 | 1983 | 526 | 0.040 |
Why?
|
| Drug Eruptions | 1 | 1980 | 256 | 0.040 |
Why?
|
| Intestinal Perforation | 1 | 2019 | 102 | 0.040 |
Why?
|
| Constriction, Pathologic | 1 | 2019 | 310 | 0.040 |
Why?
|
| Prosthesis Failure | 1 | 2019 | 206 | 0.040 |
Why?
|
| Cell Proliferation | 3 | 2016 | 7226 | 0.040 |
Why?
|
| Feces | 3 | 1985 | 770 | 0.040 |
Why?
|
| Anastomosis, Surgical | 1 | 2019 | 371 | 0.040 |
Why?
|
| Fetal Alcohol Spectrum Disorders | 1 | 2016 | 15 | 0.040 |
Why?
|
| Flow Cytometry | 2 | 2014 | 3033 | 0.040 |
Why?
|
| Animals | 6 | 2018 | 59536 | 0.040 |
Why?
|
| Cell Movement | 2 | 2016 | 2466 | 0.040 |
Why?
|
| Immune System | 1 | 2018 | 279 | 0.040 |
Why?
|
| Lipid Peroxidation | 1 | 2016 | 157 | 0.030 |
Why?
|
| Abdominal Pain | 1 | 2019 | 369 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2018 | 4971 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 2013 | 5767 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2018 | 842 | 0.030 |
Why?
|
| Apoptosis | 3 | 2016 | 7591 | 0.030 |
Why?
|
| Calcinosis | 1 | 1999 | 423 | 0.030 |
Why?
|
| Risk Factors | 2 | 2019 | 17523 | 0.030 |
Why?
|
| Drug Administration Schedule | 4 | 2019 | 3472 | 0.030 |
Why?
|
| Gastric Mucosa | 1 | 1999 | 613 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2019 | 1391 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2018 | 584 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2018 | 9244 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 672 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 521 | 0.030 |
Why?
|
| Ethanol | 1 | 2016 | 264 | 0.030 |
Why?
|
| Deglutition Disorders | 1 | 2019 | 447 | 0.030 |
Why?
|
| CTLA-4 Antigen | 1 | 2018 | 657 | 0.030 |
Why?
|
| Specimen Handling | 1 | 1976 | 299 | 0.030 |
Why?
|
| Multigene Family | 1 | 2016 | 425 | 0.030 |
Why?
|
| Clindamycin | 1 | 1974 | 50 | 0.030 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2018 | 673 | 0.030 |
Why?
|
| Doxorubicin | 2 | 1982 | 3005 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2018 | 677 | 0.030 |
Why?
|
| Methane | 2 | 1985 | 19 | 0.030 |
Why?
|
| Vascular Surgical Procedures | 1 | 1980 | 655 | 0.030 |
Why?
|
| Anthraquinones | 2 | 1983 | 27 | 0.030 |
Why?
|
| Spinal Neoplasms | 1 | 2019 | 631 | 0.030 |
Why?
|
| Mice | 4 | 2016 | 34495 | 0.030 |
Why?
|
| Sex Factors | 1 | 2018 | 2139 | 0.030 |
Why?
|
| Kidney Transplantation | 1 | 1999 | 755 | 0.030 |
Why?
|
| Weight Loss | 1 | 2017 | 627 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2016 | 1338 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2014 | 886 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2019 | 1375 | 0.030 |
Why?
|
| Cell Separation | 1 | 2014 | 612 | 0.030 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2018 | 1048 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 1062 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2013 | 518 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2019 | 2218 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2016 | 803 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 4298 | 0.020 |
Why?
|
| Antibiotics, Antineoplastic | 2 | 1986 | 726 | 0.020 |
Why?
|
| Hypertension | 1 | 1980 | 1503 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2014 | 1313 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 1994 | 901 | 0.020 |
Why?
|
| Recurrence | 1 | 2019 | 4758 | 0.020 |
Why?
|
| Color | 1 | 1990 | 66 | 0.020 |
Why?
|
| Sigmoidoscopy | 2 | 1984 | 47 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 1070 | 0.020 |
Why?
|
| Lymphatic Metastasis | 2 | 2013 | 4844 | 0.020 |
Why?
|
| Platelet Count | 4 | 1983 | 490 | 0.020 |
Why?
|
| Photography | 1 | 1990 | 139 | 0.020 |
Why?
|
| Drug Therapy, Combination | 4 | 1982 | 2315 | 0.020 |
Why?
|
| Protein Binding | 1 | 2016 | 3438 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2016 | 4143 | 0.020 |
Why?
|
| DNA Repair | 1 | 2016 | 1872 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2010 | 445 | 0.020 |
Why?
|
| DNA Damage | 1 | 2016 | 1954 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2016 | 2359 | 0.020 |
Why?
|
| Pregnancy | 2 | 2016 | 7573 | 0.020 |
Why?
|
| Incidental Findings | 1 | 2010 | 272 | 0.020 |
Why?
|
| Lymphoma | 1 | 1977 | 1467 | 0.020 |
Why?
|
| Histones | 1 | 2016 | 1466 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 4320 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2014 | 2450 | 0.020 |
Why?
|
| von Willebrand Diseases | 1 | 1968 | 61 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2016 | 5637 | 0.020 |
Why?
|
| Palliative Care | 1 | 2019 | 2037 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 2 | 1985 | 418 | 0.020 |
Why?
|
| Colitis, Ulcerative | 2 | 2004 | 268 | 0.020 |
Why?
|
| Leukocyte Count | 3 | 1983 | 684 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 2291 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2018 | 9180 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 2216 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 3639 | 0.020 |
Why?
|
| Choristoma | 1 | 1986 | 85 | 0.020 |
Why?
|
| Oxazoles | 1 | 1986 | 60 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 14889 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2018 | 6869 | 0.020 |
Why?
|
| Isoxazoles | 1 | 1986 | 81 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 7548 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2013 | 5395 | 0.020 |
Why?
|
| Intestines | 1 | 2010 | 686 | 0.020 |
Why?
|
| Skatole | 1 | 1985 | 1 | 0.020 |
Why?
|
| Esophageal and Gastric Varices | 1 | 1986 | 85 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2018 | 3341 | 0.020 |
Why?
|
| Hydrogen | 1 | 1985 | 58 | 0.020 |
Why?
|
| Disease Progression | 1 | 2016 | 6682 | 0.020 |
Why?
|
| Genomics | 1 | 2016 | 2738 | 0.020 |
Why?
|
| Barium Sulfate | 1 | 1984 | 40 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2010 | 1301 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2013 | 3821 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 3343 | 0.020 |
Why?
|
| Digestive System Diseases | 1 | 1984 | 35 | 0.020 |
Why?
|
| Infliximab | 1 | 2004 | 130 | 0.010 |
Why?
|
| Flucytosine | 1 | 1983 | 30 | 0.010 |
Why?
|
| Mitosporic Fungi | 1 | 1983 | 15 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2019 | 13658 | 0.010 |
Why?
|
| Aminoacridines | 1 | 1983 | 23 | 0.010 |
Why?
|
| Tegafur | 1 | 1983 | 50 | 0.010 |
Why?
|
| Esophagus | 1 | 1986 | 553 | 0.010 |
Why?
|
| Azirines | 1 | 1982 | 5 | 0.010 |
Why?
|
| Aziridines | 1 | 1982 | 17 | 0.010 |
Why?
|
| Vindesine | 1 | 1982 | 11 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2013 | 6150 | 0.010 |
Why?
|
| Bile | 1 | 1982 | 81 | 0.010 |
Why?
|
| Benzoquinones | 1 | 1982 | 108 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 7702 | 0.010 |
Why?
|
| Amphotericin B | 1 | 1983 | 289 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2013 | 4078 | 0.010 |
Why?
|
| Phosphonoacetic Acid | 1 | 1981 | 18 | 0.010 |
Why?
|
| Liver Neoplasms | 3 | 1984 | 4557 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 1994 | 5687 | 0.010 |
Why?
|
| Infusions, Intra-Arterial | 1 | 1981 | 171 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2014 | 15862 | 0.010 |
Why?
|
| Aspergillosis | 1 | 1983 | 246 | 0.010 |
Why?
|
| Organophosphorus Compounds | 1 | 1981 | 101 | 0.010 |
Why?
|
| Aspartic Acid | 1 | 1981 | 126 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 7222 | 0.010 |
Why?
|
| Hypotension | 1 | 1982 | 210 | 0.010 |
Why?
|
| Adolescent | 5 | 1994 | 31252 | 0.010 |
Why?
|
| Cholestasis | 1 | 1982 | 203 | 0.010 |
Why?
|
| Drainage | 1 | 1982 | 416 | 0.010 |
Why?
|
| Pruritus | 1 | 1980 | 87 | 0.010 |
Why?
|
| Hepatic Artery | 1 | 1981 | 240 | 0.010 |
Why?
|
| Collagen | 1 | 1983 | 752 | 0.010 |
Why?
|
| Anesthesia, Local | 1 | 1980 | 66 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 6009 | 0.010 |
Why?
|
| Neoplasm Metastasis | 6 | 1986 | 5112 | 0.010 |
Why?
|
| Indoles | 1 | 1985 | 1009 | 0.010 |
Why?
|
| Hemoglobins | 2 | 1982 | 477 | 0.010 |
Why?
|
| Liver Cirrhosis | 1 | 1986 | 941 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 14551 | 0.010 |
Why?
|
| Esophagogastric Junction | 1 | 1982 | 543 | 0.010 |
Why?
|
| Abdominal Neoplasms | 1 | 1980 | 231 | 0.010 |
Why?
|
| Nausea | 3 | 1986 | 525 | 0.010 |
Why?
|
| Liver | 2 | 1986 | 2961 | 0.010 |
Why?
|
| Endoscopy | 3 | 1986 | 479 | 0.010 |
Why?
|
| Chromium Radioisotopes | 1 | 1976 | 9 | 0.010 |
Why?
|
| Melena | 1 | 1976 | 8 | 0.010 |
Why?
|
| Intubation, Gastrointestinal | 1 | 1977 | 79 | 0.010 |
Why?
|
| Methods | 1 | 1976 | 189 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2016 | 10331 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1976 | 191 | 0.010 |
Why?
|
| False Negative Reactions | 1 | 1976 | 275 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 1976 | 355 | 0.010 |
Why?
|
| Foreign Bodies | 1 | 1977 | 145 | 0.010 |
Why?
|
| Graft vs Host Disease | 1 | 1986 | 2638 | 0.010 |
Why?
|
| Liver Diseases | 1 | 1980 | 574 | 0.010 |
Why?
|
| Leukopenia | 2 | 1986 | 151 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 1984 | 3719 | 0.010 |
Why?
|
| Breath Tests | 2 | 1985 | 177 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 1999 | 2843 | 0.010 |
Why?
|
| Cathartics | 2 | 1983 | 42 | 0.010 |
Why?
|
| Mitoxantrone | 2 | 1983 | 216 | 0.010 |
Why?
|
| Fiber Optic Technology | 2 | 1983 | 142 | 0.010 |
Why?
|
| Injections, Intravenous | 2 | 1983 | 573 | 0.010 |
Why?
|
| Rectum | 1 | 1974 | 467 | 0.010 |
Why?
|
| Young Adult | 1 | 2010 | 21445 | 0.010 |
Why?
|
| Bone Marrow | 3 | 1983 | 2358 | 0.010 |
Why?
|
| Random Allocation | 2 | 1983 | 703 | 0.010 |
Why?
|
| Carcinoma | 1 | 1981 | 2578 | 0.010 |
Why?
|
| Factor VIII | 1 | 1968 | 75 | 0.000 |
Why?
|
| Tryptophan | 1 | 1985 | 127 | 0.000 |
Why?
|
| Vomiting | 1 | 1986 | 354 | 0.000 |
Why?
|
| Intestinal Absorption | 1 | 1985 | 211 | 0.000 |
Why?
|
| Aclarubicin | 1 | 1983 | 2 | 0.000 |
Why?
|
| Naphthacenes | 1 | 1983 | 4 | 0.000 |
Why?
|
| Amsacrine | 1 | 1983 | 61 | 0.000 |
Why?
|
| Colon, Sigmoid | 1 | 1982 | 42 | 0.000 |
Why?
|
| Enema | 1 | 1982 | 47 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1968 | 1819 | 0.000 |
Why?
|
| Floxuridine | 1 | 1981 | 38 | 0.000 |
Why?
|
| Ulcer | 1 | 1981 | 78 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 1984 | 11538 | 0.000 |
Why?
|
| Barrett Esophagus | 1 | 1986 | 569 | 0.000 |
Why?
|
| Dyspepsia | 1 | 1981 | 103 | 0.000 |
Why?
|
| Duodenum | 1 | 1981 | 149 | 0.000 |
Why?
|
| Bone Marrow Transplantation | 1 | 1986 | 1581 | 0.000 |
Why?
|
| Bacteria | 1 | 1985 | 611 | 0.000 |
Why?
|
| Blood Vessels | 1 | 1981 | 217 | 0.000 |
Why?
|
| Child | 2 | 1981 | 29154 | 0.000 |
Why?
|
| Administration, Oral | 1 | 1983 | 1544 | 0.000 |
Why?
|
| Stomach | 1 | 1981 | 387 | 0.000 |
Why?
|
| Gastritis | 1 | 1981 | 373 | 0.000 |
Why?
|
| Intestinal Fistula | 1 | 1977 | 44 | 0.000 |
Why?
|
| Risk | 1 | 1981 | 1972 | 0.000 |
Why?
|
| Jejunum | 1 | 1977 | 216 | 0.000 |
Why?
|
| Combined Modality Therapy | 1 | 1987 | 8865 | 0.000 |
Why?
|
| Gastrostomy | 1 | 1977 | 180 | 0.000 |
Why?
|
| Cisplatin | 1 | 1981 | 2432 | 0.000 |
Why?
|
| Sepsis | 1 | 1977 | 652 | 0.000 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 1986 | 6915 | 0.000 |
Why?
|